Synovics Pharmaceuticals, Inc. (SYVC)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

At close: Jan 30, 2026

9,900% (1Y)

Market Cap	3.65K
Revenue (ttm)	19.09M
Net Income (ttm)	-5.04M
Shares Out	36.49M
EPS (ttm)	-0.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400
Average Volume	10,425
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0001
Beta	170.97
RSI	53.86
Earnings Date	n/a

About Synovics Pharmaceuticals

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its nam... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1983

Employees 155

Stock Exchange OTCMKTS

Ticker Symbol SYVC

Full Company Profile

Financial Performance

In fiscal year 2008, Synovics Pharmaceuticals's revenue was $25.96 million, an increase of 10.62% compared to the previous year's $23.47 million. Losses were -$4.01 million, -80.79% less than in 2007.

Financial Statements

News

There is no news available yet.